3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 2/3
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Oesophagogastric Cancer
1
Inflammatory Breast Neoplasms
1
Carcinoma, Ductal, Breast
1
Breast Diseases
1
Interventions
Paclitaxel
2
Taxes
1
Neoadjuvant Therapy
1
Letrozole
1
Lapatinib
1
Gonadotropin-Releasing Hormone
1
Doxorubicin
1
Cisplatin
1
Carboplatin
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Inflammatory Breast Neoplasms
×
Lapatinib
×
Clear all
NCT01426880
2016-02-15
GeparSixto
GBG Forschungs GmbH
Phase 2/3
Completed
595 enrolled